NIH’s continuous submission policy provides members of review and advisory groups and reviewers with recent substantial service the benefit of submitting R01, R21, and R34 applications at any time in response to active funding opportunity announcements (FOAs) that have standard due dates. You can check your eligibility to submit applications under NIH’s continuous submission policy by logging into eRA Commons …. NIH recently published consolidated guidance on continuous submission. ….

Appointed members of standing NIH study sections, NIH Boards of Scientific Counselors, NIH Advisory Boards or Councils, or NIH Program Advisory Committees are all eligible for continuous submission (submitting R01, ….

Yes, as of January 1, 2017 award recipients must submit a Final Research Performance Progress Report (“Final RPPR”) no later than 120 calendar days from the end of the award (“period of performance” end date). As described in NIH Guide notice NOT-OD-17-022, ….

Yes. The information submitted in the Project Outcomes section of the Final RPPR will be made accessible to the general public via NIH’s Research Portfolio On-line Reporting Tools (RePORT). ….

As per NIH’s policy, investigators and clinical trial staff are expected to maintain their GCP training through refresher courses every three years. For more information read the NIH Guide notice announcing the policy and other related FAQs.

Institutions need not regard the NIH Good Clinical Practice (GCP) policy’s effective date as a deadline by which we expect NIH-funded investigators and clinical trial staff involved in the design, conduct, oversight, or management of clinical trials to complete GCP training. Rather, as long as steps are being taken to meet the expectation, e.g., staff who have not yet been trained have signed up for a course, the training itself can be completed after the effective date. For more information, ….

The GCP policy does not specify that a particular GCP course or program be taken. The policy includes links to GCP training courses sponsored by NIAID and NIDA. In addition, NCATS has developed a GCP training program geared to behavioral clinical trial investigators. These courses are free of charge. Other free courses as well as fee-based courses are available.

For more information read the NIH Guide notice announcing the policy and other related FAQs.

With the exception of grant programs that have an effort requirement, or where terms and conditions prohibit such reductions, NIH will not require prior approval for the reduction in effort for Senior/Key personnel named in the Notice of Award (NoA) during a no-cost extension. However, consistent with the NIH Grants Policy Statement Chapter 8.1.1.3, recipients are reminded that for active NIH awards, the PD/PI and other Senior/key personnel named in the NoA must devote a measurable level of effort.

Yes, the PD/PI and other Senior/key personnel named in the notice of award must devote a measurable level of effort to the project. If the level of effort is reduced by 25 percent or more from what was approved in the initial competing year award, prior approval from NIH would be required. (See NIH Grants Policy Statement Chapter 8.1.2.6). With the exception of grant programs that have an effort requirement, or where terms and conditions prohibit such reductions, NIH does not require prior approval for the reduction in effort for Senior/key personnel named in the notice of award during a no-cost extension.

The authentication plan is only for established key biological and/or chemical resources, as defined on our website. Do not include plans for the authentication of data sets, databases, machinery, or electronics in the authentication plan attachment. If the Research Strategy does not propose use of key biological and/or chemical resources, the ….